Salmon Sean's Insider Trades & SAST Disclosures
Salmon Sean's most recent trade in Medtronic Plc was a trade of 645 Ordinary Shares done at an average price of $82.5 . Disclosure was reported to the exchange on Dec. 16, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Salmon Sean.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Medtronic Plc | Sean M. Salmon | EVP & President Cardiovascular | Payment of exercise price or tax liability using portion of securities received from the company at price $ 82.48 per share. | 16 Dec 2024 | 645 | 64,722 (0%) | 0% | 82.5 | 53,200 | Ordinary Shares |
| Medtronic Plc | Sean Salmon | EVP & President Cardiovascular | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Aug 2024 | 5,462 | 68,546 (0%) | 0% | 0 | Ordinary Shares | |
| Medtronic Plc | Sean Salmon | EVP & President Cardiovascular | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Aug 2024 | 5,462 | 0 | - | - | Performance Share Units | |
| Medtronic Plc | Sean Salmon | EVP & President Cardiovascular | Payment of exercise price or tax liability using portion of securities received from the company at price $ 81.51 per share. | 02 Aug 2024 | 2,779 | 65,110 (0%) | 0% | 81.5 | 226,516 | Ordinary Shares |
| Medtronic Plc | Sean Salmon | EVP & President Cardiovascular | Payment of exercise price or tax liability using portion of securities received from the company at price $ 81.51 per share. | 02 Aug 2024 | 657 | 67,889 (0%) | 0% | 81.5 | 53,552 | Ordinary Shares |
| Medtronic Plc | Sean Salmon | EVP & President Cardiovascular | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jul 2024 | 106,260 | 106,260 | - | - | Stock Option (Right to Buy) | |
| Medtronic Plc | Sean Salmon | EVP & President Cardiovascular | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jul 2024 | 35,938 | 35,938 | - | - | Performance Share Unit | |
| Medtronic Plc | Sean Salmon | EVP & President Cardiovascular | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jul 2024 | 14,375 | 63,084 (0%) | 0% | 0 | Ordinary Shares | |
| Medtronic Plc | Sean Salmon | EVP & President Cardiovascular | Sale of securities on an exchange or to another person at price $ 85.12 per share. | 21 Feb 2024 | 16,035 | 48,289 (0%) | 0% | 85.1 | 1,364,899 | Ordinary Shares |
| Medtronic Plc | Sean Salmon | EVP & President Cardiovascular | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Feb 2024 | 16,035 | 0 | - | - | Stock Option (Right to Buy) | |
| Medtronic Plc | Sean Salmon | EVP & President Cardiovascular | Exercise or conversion of derivative security received from the company (such as an option) at price $ 74.84 per share. | 21 Feb 2024 | 16,035 | 78,984 (0%) | 0% | 74.8 | 1,200,059 | Ordinary Shares |
| Medtronic Plc | Salmon Sean | EVP & President Cardiovascular | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Feb 2024 | 13,066 | 0 | - | - | Stock Option (Right to Buy) | |
| Medtronic Plc | Salmon Sean | EVP & President Cardiovascular | Exercise or conversion of derivative security received from the company (such as an option) at price $ 62.76 per share. | 21 Feb 2024 | 13,066 | 62,949 (0%) | 0% | 62.8 | 820,022 | Ordinary Shares |
| Medtronic Plc | Salmon Sean | EVP & President Cardiovascular | Sale of securities on an exchange or to another person at price $ 85.15 per share. | 21 Feb 2024 | 13,066 | 64,324 (0%) | 0% | 85.2 | 1,112,570 | Ordinary Shares |
| Medtronic Plc | Salmon Sean | EVP & President Cardiovascular | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Feb 2024 | 1,594 | 13,066 | - | - | Stock Option (Right to Buy) | |
| Medtronic Plc | Sean Salmon | EVP & President Cardiovascular | Sale of securities on an exchange or to another person at price $ 85.06 per share. | 21 Feb 2024 | 1,594 | 77,390 (0%) | 0% | 85.1 | 135,586 | Ordinary Shares |
| Medtronic Plc | Salmon Sean | EVP & President Cardiovascular | Exercise or conversion of derivative security received from the company (such as an option) at price $ 62.76 per share. | 21 Feb 2024 | 1,594 | 49,833 (0%) | 0% | 62.8 | 100,039 | Ordinary Shares |
| Medtronic Plc | Sean Salmon | EVP & President Cardiovascular | Payment of exercise price or tax liability using portion of securities received from the company at price $ 79.27 per share. | 08 Dec 2023 | 435 | 48,103 (0%) | 0% | 79.3 | 34,482 | Ordinary Shares |
| Medtronic Plc | Sean Salmon | EVP & President Cardiovascular | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Aug 2023 | 5,604 | 0 | - | - | Performance Share Units | |
| Medtronic Plc | Sean Salmon | EVP & President Cardiovascular | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Aug 2023 | 5,604 | 52,095 (0%) | 0% | 0 | Ordinary Shares | |
| Medtronic Plc | Sean Salmon | EVP & President Cardiovascular | Payment of exercise price or tax liability using portion of securities received from the company at price $ 84.49 per share. | 03 Aug 2023 | 4,369 | 47,726 (0%) | 0% | 84.5 | 369,137 | Ordinary Shares |
| Medtronic Plc | Sean Salmon | EVP & President Cardiovascular | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jul 2023 | 68,196 | 68,196 | - | - | Stock Option (Right to Buy) | |
| Medtronic Plc | Sean Salmon | EVP & President Cardiovascular | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jul 2023 | 21,214 | 21,214 | - | - | Performance Share Units | |
| Medtronic Plc | Sean Salmon | EVP & President Cardiovascular | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jul 2023 | 9,686 | 46,290 (0%) | 0% | 0 | Ordinary Shares | |
| Medtronic Plc | Sean Salmon | EVP & President Cardiovascular | Sale of securities on an exchange or to another person at price $ 80.50 per share. | 13 Dec 2022 | 16,631 | 36,088 (0%) | 0% | 80.5 | 1,338,736 | Ordinary Shares |
| Medtronic Plc | Sean Salmon | EVP & President Cardiovascular | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Dec 2022 | 14,823 | 0 | - | - | Stock Option (Right to Buy) | |
| Medtronic Plc | Sean Salmon | EVP & President Cardiovascular | Exercise or conversion of derivative security received from the company (such as an option) at price $ 55.32 per share. | 13 Dec 2022 | 14,823 | 52,719 (0%) | 0% | 55.3 | 820,008 | Ordinary Shares |
| Medtronic Plc | Sean Salmon | EVP & President Cardiovascular | Exercise or conversion of derivative security received from the company (such as an option) at price $ 55.32 per share. | 13 Dec 2022 | 1,808 | 37,896 (0%) | 0% | 55.3 | 100,019 | Ordinary Shares |
| Medtronic Plc | Sean Salmon | EVP & President Cardiovascular | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Dec 2022 | 1,808 | 0 | - | - | Stock Option (Right to Buy) | |
| Medtronic Plc | Sean Salmon | EVP & President Cardiovascular | Payment of exercise price or tax liability using portion of securities received from the company at price $ 79.04 per share. | 07 Dec 2022 | 300 | 36,088 (0%) | 0% | 79.0 | 23,712 | Ordinary Shares |
| Medtronic Plc | Sean Salmon | EVP & President Cardiovascular | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Aug 2022 | 67,924 | 67,924 | - | - | Stock Option (Right to Buy) | |
| Medtronic Plc | Sean Salmon | EVP & President Cardiovascular | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Aug 2022 | 21,487 | 21,487 | - | - | Performance Share Units | |
| Medtronic Plc | Sean Salmon | EVP & President Cardiovascular | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Aug 2022 | 8,595 | 36,214 (0%) | 0% | 0 | Ordinary Shares | |
| Medtronic Plc | Sean Salmon | EVP & President Cardiovascular | Sale or transfer of securities back to the company at price $ 0.00 per share. | 29 Jul 2022 | 5,808 | 27,619 (0%) | 0% | 0 | Ordinary Shares | |
| Medtronic Plc | Sean Salmon | EVP & Pres Diabetes/Cardiovasc | Payment of exercise price or tax liability using portion of securities received from the company at price $ 104.94 per share. | 15 Dec 2021 | 89 | 33,083 (0%) | 0% | 104.9 | 9,340 | Ordinary Shares |
| Medtronic Plc | Sean Salmon | EVP & Pres Diabetes/Cardiovasc | Payment of exercise price or tax liability using portion of securities received from the company at price $ 122.98 per share. | 05 Nov 2021 | 245 | 33,172 (0%) | 0% | 123.0 | 30,130 | Ordinary Shares |
| Medtronic Plc | Sean Salmon | EVP & Pres Diabetes/Cardiovasc | Sale of securities on an exchange or to another person at price $ 134.08 per share. | 25 Aug 2021 | 21,129 | 33,329 (0%) | 0% | 134.1 | 2,832,976 | Ordinary Shares |
| Medtronic Plc | Sean Salmon | EVP & Pres Diabetes/Cardiovasc | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Aug 2021 | 21,129 | 0 | - | - | Stock Option (Right to Buy) | |
| Medtronic Plc | Sean Salmon | EVP & Pres Diabetes/Cardiovasc | Exercise or conversion of derivative security received from the company (such as an option) at price $ 38.81 per share. | 25 Aug 2021 | 21,129 | 54,458 (0%) | 0% | 38.8 | 820,016 | Ordinary Shares |
| Medtronic Plc | Sean Salmon | EVP & Pres Diabetes/Cardiovasc | Sale of securities on an exchange or to another person at price $ 134.09 per share. | 25 Aug 2021 | 7,290 | 33,329 (0%) | 0% | 134.1 | 977,516 | Ordinary Shares |
| Medtronic Plc | Sean Salmon | EVP & Pres Diabetes/Cardiovasc | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Aug 2021 | 4,713 | 0 | - | - | Stock Option (Right to Buy) | |
| Medtronic Plc | Sean Salmon | EVP & Pres Diabetes/Cardiovasc | Exercise or conversion of derivative security received from the company (such as an option) at price $ 38.20 per share. | 25 Aug 2021 | 4,713 | 40,619 (0%) | 0% | 38.2 | 180,037 | Ordinary Shares |
| Medtronic Plc | Sean Salmon | EVP & Pres Diabetes/Cardiovasc | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Aug 2021 | 2,577 | 0 | - | - | Stock Option (Right to Buy) | |
| Medtronic Plc | Sean Salmon | EVP & Pres Diabetes/Cardiovasc | Exercise or conversion of derivative security received from the company (such as an option) at price $ 38.81 per share. | 25 Aug 2021 | 2,577 | 35,906 (0%) | 0% | 38.8 | 100,013 | Ordinary Shares |
| Medtronic Plc | Sean Salmon | EVP & Pres Diabetes/Cardiovasc | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Aug 2021 | 46,867 | 46,867 | - | - | Stock Option (Right to Buy) | |
| Medtronic Plc | Sean Salmon | EVP & Pres Diabetes/Cardiovasc | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Aug 2021 | 13,714 | 13,714 | - | - | Performance Share Units | |
| Medtronic Plc | Sean Salmon | EVP & Pres Diabetes/Cardiovasc | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Aug 2021 | 5,486 | 33,329 (0%) | 0% | 0 | Ordinary Shares | |
| Medtronic Plc | Sean Salmon | EVP & Pres Diabetes/Cardiovasc | Payment of exercise price or tax liability using portion of securities received from the company at price $ 131.31 per share. | 02 Aug 2021 | 2,272 | 27,843 (0%) | 0% | 131.3 | 298,336 | Ordinary Shares |
| Medtronic Plc | Sean Salmon | EVP & Pres Diabetes/Cardiovasc | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Aug 2021 | 1,085 | 1,085 | - | - | Stock Option (Right to Buy) | |
| Medtronic Plc | Sean Salmon | EVP & Group President Diabetes | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2021 | 16,314 | 16,314 | - | - | Stock Option (Right to Buy) | |
| Medtronic Plc | Sean Salmon | EVP & Group President Diabetes | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2021 | 4,947 | 4,947 | - | - | Performance Share Units | |
| Medtronic Plc | Sean Salmon | EVP & Group President Diabetes | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2021 | 1,979 | 30,007 (0%) | 0% | 0 | Ordinary Shares | |
| Medtronic Plc | Sean Salmon | EVP & Group President Diabetes | Payment of exercise price or tax liability using portion of securities received from the company at price $ 103.13 per share. | 03 Nov 2020 | 220 | 27,900 (0%) | 0% | 103.1 | 22,689 | Ordinary Shares |
| Medtronic Plc | Sean Salmon | EVP & Group President Diabetes | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Oct 2020 | 11,042 | 11,042 | - | - | Performance Share Units | |
| Medtronic Plc | Sean Salmon | EVP & Group President Diabetes | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Aug 2020 | 45,340 | 45,340 | - | - | Stock Option (Right to Buy) | |
| Medtronic Plc | Sean Salmon | EVP & Group President Diabetes | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Aug 2020 | 30,227 | 30,227 | - | - | Stock Option (Right to Buy) | |
| Medtronic Plc | Sean Salmon | EVP & Group President Diabetes | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Aug 2020 | 4,932 | 28,041 (0%) | 0% | 0 | Ordinary Shares | |
| Medtronic Plc | Sean Salmon | EVP & Group President Diabetes | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Aug 2020 | 1,575 | 1,575 | - | - | Stock Option (Right to Buy) | |
| Medtronic Plc | Sean Salmon | EVP & Group President Diabetes | Payment of exercise price or tax liability using portion of securities received from the company at price $ 96.48 per share. | 31 Jul 2020 | 2,569 | 23,109 (0%) | 0% | 96.5 | 247,857 | Ordinary Shares |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges